In providing market access support to our clients. Mapi Values calls on a team of highly skilled and knowledgeable individuals. The senior members of our Market Access team have a wealth of experience of designing and implementing pharmaceutical market access strategies, as well as unrivalled insight into the local and national requirements of HTA and reimbursement authorities. Details of some key members of the team are given below:

Jeanni van Loon’s career has included senior positions in both the pharmaceutical industry and healthcare service companies. She set up the global health economics department of a major pharmaceutical company (Organon) as well as working for the outcomes research consultancy division of an international CRO. Jeanni was involved in revising the pharmacoeconomic guidelines issued by the Dutch authorities and has experience of reimbursement submissions in all major European countries.

Jeroen Jansen has advanced skills in evidence synthesis, including the use of Bayesian methods for meta-analysis of direct and indirect comparisons (mixed treatment comparisons). Jeroen has run a number of training courses on evidence synthesis methodology, as well as having extensive experience in developing economic models and preparing reimbursement dossiers.

Christopher Evans has held positions as Assistant Director of Health Economics and Outcomes Research at Astra Pharmaceuticals and as a health economist in a large contract research organization in the United States, France and the Netherlands. Chris specializes in the design and execution of original research in health technology, cost effectiveness, pricing and marketing. In addition, he has conducted research into the methodological aspects of pharmacoeconomics and the use and relevance of this type of information to decision-makers.